FDA Drug Approval, N017381, SILVADENE
FDA Drug Approval, N017381, SILVADENE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 017381
Company: KING PHARMS LLC
Drug Name: SILVADENE
Active Ingredients: SILVER SULFADIAZINE
Strength: 1%
Dosage Form/Route: CREAM;TOPICAL
Action Date: 11/26/1973
Marketing Status: Prescription
Submission Classification: Type 2 - New Active Ingredient
Company: KING PHARMS LLC
Drug Name: SILVADENE
Active Ingredients: SILVER SULFADIAZINE
Strength: 1%
Dosage Form/Route: CREAM;TOPICAL
Action Date: 11/26/1973
Marketing Status: Prescription
Submission Classification: Type 2 - New Active Ingredient
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details